A special type of synthetic sugar could be the latest weapon in the fight against superbugs. A team of scientists from the University of Queensland and Queensland biotechnology company Alchemia have discovered a potential new class of antibiotics inspired by sugar molecules produced by bacteria.
New antibiotics to which bacteria are unlikely to develop resistance are urgently needed to combat the rise of drug-resistant bacteria.
The research, led by professor Matt Cooper and Dr. Johannes Zuegg from UQ's Institute for Molecular Bioscience (IMB) in partnership with Alchemia, was published in scientific journal Nature Communications.
Cooper, who is director of the IMB Centre for Superbug Solutions, says bacteria are less likely to become resistant to an antibiotic based on a modified version of their own sugar. "Bacteria have cell walls similar to the walls of a brick house, except instead of mortar the walls are held together by sugar polymers. But if you add one of our modified sugar molecules, they stop the linking process, destroying the cell wall and killing the bacteria. The cell wall has been a target for antibiotics such as penicillin and vancomycin before, but the difference here is that we are stopping a centrally important part of the cell wall linking process."
Zuegg says the team examined hundreds of versions of Alchemia's modified sugar molecules to find those that will kill bacteria and are non-toxic to human cells. "Most molecules screened to become drugs have a flat, planar shape, whereas these molecules are three dimensional. This means we can build on the sugar core in a variety of ways to make thousands of different combinations in three dimensional space."
The team included researchers from University of Warwick in the UK, Academia Sinica in Taiwan and Ghent University in Belgium.
The work was supported by Alchemia, the National Health and Medical Research Council, Bayer Animal Health and the Wellcome Trust.
Source: University of Queensland
Gag Order Puts Public Health at Risk, APIC Urges Immediate Action
February 4th 2025APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.